Tomasz Wałęsa will after 6 successful years as CEO for HTL-STREFA, having grown the business by almost 10% per year and expanded the business into new attractive segments, step down as CEO to pursue new opportunities. The Board would like to thank Tomasz for many years of loyal service to HTL-STREFA and for positioning the company for the future with state-of-the-art production quality and efficiency. These are strong features that give HTL-STREFA a unique market position and something that will be maintained and expanded going forward.

At the same time the Board of Directors of HTL-STREFA is pleased to announce that Mikkel Danvold is to be appointed as new CEO of the company. Mikkel Danvold comes most recently from a position as Senior Vice President of APAC & Emerging Markets in GN Hearing, part of GN Store Nord, which is one of the world’s largest providers of hearing instruments and diagnostic equipment with approximately €700m of sales in over 80 countries. In his most recent role, Mikkel covered all of Asia Pacific, Eastern Europe, Russia, Middle East, Africa as well as Latin America. Mikkel Danvold has thus broad and global experience from the medtech industry and a proven track record in successful commercial execution. He has held several leadership positions during his tenure with GN Store Nord and has achieved fast sales growth and increasing profit. Mikkel will, together with the current HTL-STREFA management team, focus on accelerating HTL-STREFA’s strong growth trajectory and ability to further drive the commercial agenda.

“I would like to take the opportunity to thank Tomasz for his many and great contributions to HTL-STREFA and wish him the best of luck for the next phase of his professional life.”
It is very exciting to start working together with Mikkel Danvold. HTL-STREFA is a uniquely positioned company with tremendous potential to grow in a number of very attractive and diversified channels in the future, where we are launching several new innovative products as well as continuing profitable growth of our existing product portfolio. Mikkel’s background and experience make him a strong fit to accelerate our ambitious growth agenda”, says Gerard van Odijk, Chairman of HTL-STREFA.
”HTL-STREFA is a strong performing company and I look very much forward to meeting and getting to know all my new colleagues as well as customers at HTL-STREFA. I see many attractive growth opportunities to pursue and execute on, both short and long term, which makes me confident that we will accelerate our already strong business momentum. With our uniquely high quality product offering, as well as our exciting future product pipeline, we need to make sure that even more end-users and healthcare professionals will benefit in their everyday life from our products.” says Mikkel Danvold.

HTL-STREFA is the global leader in single-use devices for safety blood micro-sampling, with a growing presence in pen-based injection needle and safety hypodermic injection needle markets.

Best regards,
The HTL-STREFA Board of Directors